University - Industry Cooperation Group of Kyung Hee University;Navipharm Co., Ltd.
发明人:
申请号：
EP18860530.7
公开号：
EP3715448A2
申请日:
2018.09.28
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention relates to a novel lactic acid bacterium, and more particularly, to a composition comprising Lactobacillus reuteri NK33 (KCCM12090P) or Bifidobacterium adolescentis NK98 (KCCM12297P), which is the novel lactic acid bacterium, useful in preventing and treating a neurological mental disease or an inflammatory disease.Also, the present invention relates to a composition for diagnosing a neurological mental disease, comprising a preparation for measuring a level of an intestinal microorganism, a kit comprising the same, and a method for diagnosing the neurological mental disease, comprising a step of measuring the level of the intestinal microorganism.
